Atlas Wealth LLC Provectus Biopharmaceuticals, Inc. Transaction History
Atlas Wealth LLC
- $205 Billion
- Q1 2024
A detailed history of Atlas Wealth LLC transactions in Provectus Biopharmaceuticals, Inc. stock. As of the latest transaction made, Atlas Wealth LLC holds 26,620 shares of PVCT stock, worth $3,726. This represents 0.0% of its overall portfolio holdings.
Number of Shares
26,620
Previous 26,620
-0.0%
Holding current value
$3,726
Previous $2.25 Million
116.36%
% of portfolio
0.0%
Previous 0.0%
Shares
1 transactions
Others Institutions Holding PVCT
# of Institutions
7Shares Held
229KCall Options Held
0Put Options Held
0-
Home Federal Bank Of Tennessee100KShares$14,0000.01% of portfolio
-
Lee Danner & Bass Inc50KShares$7,0000.0% of portfolio
-
Lbmc Investment Advisors, LLC22KShares$3,0800.0% of portfolio
-
Academy Capital Management Inc Waco, TX20KShares$2,8000.0% of portfolio
-
Financial Symmetry Inc Raleigh, NC10.2KShares$1,4260.0% of portfolio
About PROVECTUS BIOPHARMACEUTICALS, INC.
- Ticker PVCT
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 419,496,992
- Market Cap $58.7M
- Description
- Provectus Biopharmaceuticals, Inc., a clinical-stage biotechnology company, engages in developing immunotherapy medicines based on halogenated xanthenes. It develops PV-10, an investigational autolytic cancer immunotherapy for adult solid tumor cancers, such as melanoma and gastrointestinal tumors, including hepatocellular carcinoma; colorectal ...